CPT2: COPD Flashcards

1
Q

What is COPD?

A

COPD is characterised by chronic airway obstruction that interferes with normal breathing and is not fully reversible. It is an umbrella term for progressive lung diseases e.g. chronic bronchitis, emphysema and refractory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pathopyhsiology of COPD and the 2 processes involved?

A

COPD is caused by the body response to inhaled stimuli, causing an inflammatory reaction. The inflammation reaction causes long term, irreversible changes in the airway and pulmonary vessels. There are 2 processes involved: Chronic bronchitis and emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What role does chronic bronchitis in the pathophysiology?

What is chronic bronchitis defined as?

A

Chronic bronchitis is defined as a cough productive of sputum, occuring most days in 3 consecutive months over 2 consecutive years

Continual irritans ause the bronchi/bronchioles to become inflammed and swollen. The smooth muscle becomes thicker and the airways narrower. There is hypertrophy of goblet cells leading to increased mucus production. The cillia cannot cope with the excess production of mucus and it begins to block the airways too. Together there is narrowing of the airways which is not fully reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is emphysemea defined as?

What role does it play in the pathophysiology?

A

Defined as an enlargement of the distal airspace

Inhalation of toxic particles over time causes alveolar inflammation. This causes the walls to become thinner, eventually dissolving. There is therefore enlargement of gas exchange spaces and so gas exchange becomes less effective.

Fibrosis of the tissue can also occur leading to gas trapping and airflow limitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In COPD what are the majority of symptoms caused by?

What can this lead too?

A

The air restiacne in COPD patients can lead to hypoxia or a lack of O2 in the blood, causing the majority of symptoms

Long term hypoxia can lead to thickening of vascular smooth muscle leading to pulmonary hypertension and poor prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the symptoms of COPD?

A
  • Dyspnoea/ breathlessness
    • To begin with during periods of exertion, however as it progresses it can be at minimial exertion or at rest
  • Cough
    • Intermittent
    • Particularly early morning
    • Productive
  • Sputum prodcution
    • Increased production
    • Change in colour (purulent) or volume can be a sign of exacerbation or infection
  • Fatigue
  • Anorexia/ weightloss
  • Chest tightness
  • Wheezing
  • Repeated respiratory infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Epidemiology

A

Chances increases with age

  • UK prevalence
    • 3 million people affected (1.2million diagnosed)
    • More common in males (1.7% vs 1.4%)
    • Diagnosis – usually in mid 50’s
  • Associated with low socioeconomic status
    • Rates higher in deprived communities
  • Associated with co-morbidities
    • cardiovascular disease, lung cancer, depression, anxiety, osteoporosis, muscle weakness
  • COPD is the second largest cause of emergency admissions and so one of the most expensive inpatient conditions treated by the NHS.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the aetiology of COPD?

A

Usually caused by significant exposure to noxious particles or gas

  • Smoking
  • Air pollution
    • motor emissions, burning coal/wood
  • Occupational exposures
    • Chemicals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does a diagnosis of COPD look like in terms of what background/ charaterisitics they should have?

A

COPD should be considered in patients who are:

  • Over 35
  • Smokers or ex-smokers
    • Determine accurate smoking history.
    • Pack years = no of cigarettes daily/20 x no. of years smoked
  • Symptomatic with
    • Exertional breathlessness
    • Chronic cough
    • Regular sputum production
    • Frequent “winter bronchitis” or wheeze
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does a diagnosis of COPD involve?

A
  • Determine accurate medical history
    • Exposure to noxious fumes
    • Confirm co-morbidities
      • Increase symptoms of breathlessness
    • Allergies
  • Accurate employment history
  • Determine history of COPD or other chronic respiratory diseases
  • Airway flow obstruction and disganosis needs to be confimed by spirometry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does spiromerty measure?

A

The volume and rate at which air is forced out of the lungs after maximum inspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can spirometry assess?

A
  • •Obstructed by narrowed or inflamed airways
  • •Diagnose lung conditions
  • •Grade severity of condition
  • •Can aid assessment of inhaled therapies
  • •reversibility testing (<200ml)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is reversibility determined by spirometry for COPD?

A

As COPD has limited reversibility, after administration of a bronchodilator (Salbutamol) there should be a change of less than 200ml in the FVC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the FVC value?

A

•Total amount of air blown out after taking a deep breath in & blown out as hard and fast until your lungs are completely empty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the FEV1 value?

A

•The amount of air blown out in one second. In healthy lungs and airways you can blow out the majority of air from your lungs in one second.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the FEV1/FVC ratio?

What do values indicate?

A

The % of lung capacity that can be expelled in 1 second.

  • Declines naturally with age
  • Obstructive Lung Disease: FEV1/FVC = <70%
  • Restrictive Lung Disease: FEV1/FVC = >80%
17
Q

What ratio of FEV1/FVC is diagnostic of COPD?

A

Less than 70%

18
Q

What is the GOLD classification of COPD?

A
19
Q

What is the mMRC classifcation grading for COPD breathlessness?

A
20
Q

What does a full COPD assessment involve?

A
  • Degree of obstruction – spirometry results
  • Current nature and magnitude of patient’s symptoms
    • mMRC Score, CAT Assessment.
  • History of moderate and severe exacerbations
  • Presence of co-morbidities
21
Q

What are goals of assessment

A
  • •Review and determine the level of airflow obstruction
  • •Assess the disease’s impact on the patient’s life
  • •Reduce rate of disease progression and risk of exacerbations
  • •Ensure appropriate pharmacological and non-pharmacological management.
22
Q

What are non-pharmacological managements?

A

Non-pharmacological managements should be explore first:

  • Vaccinations
    • Annual influenza
    • one off Pneumococcal vaccine
  • Smoking cessation
    • Most effective
  • Physical activity
    • Improves lung function and circulation, enabling better use of O2 in the body and resilience of shortness of breath
  • Pulmonary rehabilitation
    • Tailored physical exercises and info programmes to help people better unferstand and manage condition
23
Q

What is the pharmacological treatment according to GOLD for COPD?

A

LAMA - superior efficacy at reducing risk of exacerbations

ICS - also reduced risk of exacerbations

Stage D:

LAMA reccomended unless highly symptomatic then LABA recommended. If high eosinophils >300 then LABA and ICS recommended

24
Q

What is pharmacological treatment according to NICE NG 115 Guidlines?

A
25
Q

It is important to regularly reassess patients to ensure goals are being met.

What does this process involve?

A

Always assess inhaler compliance and technique at every appointment

26
Q

If patients on maximised inhaler therapy and still symptomatic adjucant therapies may be used.

What are adjunct therapies are there?

A
  • Long term O2 therapy
    • Specific criteria:
      • O2 sat less than 92%
      • Very severe airway obstruction FEV1<30%
      • Cyanosis
      • Polycythemia
    • Non-smokers - due to fire risk
    • 15/hr a day
      • Very restricitve, unlikely to leave house
  • MR Theophylline
    • Can trial if still symptomatic when on LABA/LAMA/ICS + SABA or cannot use inhlaer device sucessfully
    • Caution in elderly due to changes in PK, comorbidites and drug interaction
  • Mycolytic:
    • Thins mucus and helps to clear from chest
    • Stable COPD with cough and productive sputum
  • Opiates (Morphine):
    • End stage disease, alleviates breathlessness at low doses
  • Anxiolytic:
    • Anxiety can lead to breathlessness and altered perception of breathlessness
    • Sublingual lorazepam - unlicenced use, faster onset
  • Nutritional supplements
    • Low BMI
    • Dietrican review
  • Oral Corticosteriods:
    • Iniated by specialist
    • Protect from long term side effects - GI protection and bone protection
      • Bone protec - calcuim, vit D supp, Bisphophonates
      • Gastric - PPI
27
Q

Other pharmacological management strategies

A
  • Azithromycin
    • Prophylactically to decrease the frequency of acute exacerbations of COPD
  • Selective Phosphodiesterase 4 Inhibitor (Roflumilast)
    • Treatment option depending on patient location in the UK.
  • Self-management plan
    • Rescue antibiotics/oral steroids for exacerbation
      • Oral corticosteriods for increased breathlessness
      • AB if sputum volume incr of discolouted
      • Inform health profession if start or unsure whether too
    • How to uses SABA
  • Optimise management/treatment of co-morbidities
28
Q

What are COPD exacerbations?

A

Worsening of respiratory symptoms resulting in additional therpy. They are associated with increased airway inflammation, increased mucus production and marked gas trapped in lungs

Every exacerbation contributes to perment lung damage

29
Q

What are the signs and symptoms of an acute exacerbation?

A
  • Increased breathlessness
  • Cough, wheeze
  • Increased sputum production
    • If coloured, suggestive of infective exacerbation
  • Use of accessory muscles at rest
  • New cyanosis and/or acute confusion
  • Reduction in activities of daily living
30
Q

Which symptoms indicate mild, moderate and severe exacerbations?

A
31
Q

Which patients are at highest risk of an exacerbation?

A

FEV1 <50% or history of 2 or more exacerbations in a year or have been hospitalised from an exacerbation

32
Q

When should a patient be treated at home and when should they be treated in hospital?

A
33
Q

What causes exacerbations of COPD?

A
  • Bacteria (major cause)
  • Viruses (more severe and longer to resolve)
  • Pollutants
  • Temp/ humidity changes
  • Exacerbation rates worse in winter
34
Q

How are acute exacerbations managed?

A

Increase dose/frequency of SABA:

  • pMDI via spacer (SABA)
  • via air driven nebuliser (SABA and SAMA)
    • MUST check ABGs monitor for hypercapnia (increased PaC02) or acidosis (reduced pH or increased H+)
    • Discontinue LAMA with SAMA use.

Oral steroids

  • 30mg prednisolone daily for 5 days

Consider AB if required (see next card)

35
Q

When should AB be given?

What route?

A

Antibiotic therapy only required if bacterial infection present (IECOPD):

  • sputum colour changes and increase in volume or thickness
  • increased WCC and CRP indicative of infection
  • previous exacerbation and hospital admission
  • the risk of antimicrobial resistance
  • Previous sputum culture and susceptibility results
  • ORAL usually appropriate in moderate exacerbations
  • •IV usually required in severe exacerbations
36
Q

What AB should be prescribed for exacerbations if bacterial infection present?

1st line and 2nd lines

A
37
Q

How can you tell if infection improving?

A
  • CRP down
  • WWC down
  • Spike in temp decreased
  • Sputum production decreased
38
Q

Describe the use of O2 therapy for type II respiratory failure

A
  • Type II respiratory failure is often seen in hospitalisied patients experiencing COPD exacerbations
  • pO2 decreased and pCO2 in blood increased

SaO2:

  • 88-92% at 4L/min via mask or 2L/min via nasal cannulae

Monitoring – Arterial Blood Gases:

  • pH low - acidosis (normal pH >7.26)
  • PaO2 <8kPa severe hypoxia (normal 10-13kPa)
  • •PaCO2 normal (4.6-6kPa) or raised.

Non Invasive ventilation:

  • Consider in acidosis (PaCO2 >6 kPa / pH<7.26)
  • Severe dyspnoea with accessory muscle use and fatigue
  • Persistent hypoxaemia despite O2 therapy
39
Q

Acute exacerbation follow up

A
  • Review Inhaler technique
  • Review symptoms
  • Optimise therapy – LABA/LAMA/ICS +/- oral therapy
  • Lifestyle advice: smoking cessation, vaccinations and exercise
  • Review self-management plan
    • Counsel on early signs of exacerbation and action to take
    • Consider rescue prescription for prednisolone + antibiotic (amoxicillin or doxycycline)